The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leske IB, Hantschel O. Leukemia 2024;38:2041-2045.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leske IB, Hantschel O. The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 2024;38:2041-2045.
PMID: 38879610